StemRad (Health Care) — Funding, Investors & Signals 2026

StemRad

Radiation Protection on Earth and Beyond

Founded 2011 Israel

Israel 15 employees Series C Total: $6.00M Health Care

StemRad, established in 2011 and headquartered in Israel, is a pioneer in developing, manufacturing, and distributing personal protective equipment (PPE) designed for radiation exposure. The company's slogan, "Radiation Protection on Earth and Beyond," underscores its commitment to ensuring safety in high-risk environments. StemRad stands out as the sole producer of PPE specifically engineered to shield against high-energy radiation, employing innovative selective shielding technology. Its clientele spans from first-responders, military personnel, and medical teams to astronauts, offering state-of-the-art solutions tailored to enhance radiation safety without compromising mission objectives. The company boasts a team of radiation biology experts, nuclear physicists, and industrial designers, along with the support of acclaimed scientists, including 3 Nobel Laureates. StemRad's groundbreaking science and meticulous attention to user needs have empowered the wearer with the mobility and comfort necessary to execute critical tasks while remaining protected in the event of radiation exposure. StemRad recently secured a significant $6.00M Series C investment on 03 December 2017, with notable investors such as Jeffrey Vinik and Techstars Ventures demonstrating confidence in the company's cutting-edge technology and its potential to safeguard individuals both on Earth and in outer space. With its unwavering focus on advancing radiation protection, StemRad stands at the forefront of ensuring the safety of our heroes in high-risk environments.

Funding Stage	Amount	Investors	Lead Investors	Date
Series C	••••••	2	•••• ••••	03 Dec 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Series C

••••••

•••• ••••

03 Dec 2017

FAQ About StemRad

Radiation Protection on Earth and Beyond

StemRad was founded in 2011.

StemRad is headquartered in Israel.

StemRad operates in the following industries: Health Care.

StemRad has approximately 15 employees.

StemRad has completed 1 funding round, raising a total of $6.00M. The latest funding stage is Series C.

Top alternatives and competitors to StemRad include Radiation Watch, Aurora Health Physics Services Ltd, Mirion, IRSN, Symetrica. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

StemRad and Radiation Watch are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

StemRad

General Information

Track StemRad

Discover More

About StemRad

Funding Rounds & Investors (1)

StemRad Alternatives & Competitors

FAQ About StemRad

Don't just browse. Track.